MERTOĞLU, C. Et Al. 2018. Could Endocan, a Marker of Inflammation and Endothelial Dysfunction, be a New Diagnostic Marker for Fibromyalgia?. CLINICAL LABORATORY , vol.64, no.3 , 405-410.

MERTOĞLU, C., Gunay, M., & Yerligok, O., (2018). Could Endocan, a Marker of Inflammation and Endothelial Dysfunction, be a New Diagnostic Marker for Fibromyalgia?. CLINICAL LABORATORY , vol.64, no.3, 405-410.

MERTOĞLU, CUMA, Murat Gunay, And Onur Yerligok. "Could Endocan, a Marker of Inflammation and Endothelial Dysfunction, be a New Diagnostic Marker for Fibromyalgia?," CLINICAL LABORATORY , vol.64, no.3, 405-410, 2018

MERTOĞLU, CUMA Et Al. "Could Endocan, a Marker of Inflammation and Endothelial Dysfunction, be a New Diagnostic Marker for Fibromyalgia?." CLINICAL LABORATORY , vol.64, no.3, pp.405-410, 2018

MERTOĞLU, C. Gunay, M. And Yerligok, O. (2018) . "Could Endocan, a Marker of Inflammation and Endothelial Dysfunction, be a New Diagnostic Marker for Fibromyalgia?." CLINICAL LABORATORY , vol.64, no.3, pp.405-410.

@article{article, author={CUMA MERTOĞLU Et Al. }, title={Could Endocan, a Marker of Inflammation and Endothelial Dysfunction, be a New Diagnostic Marker for Fibromyalgia?}, journal={CLINICAL LABORATORY}, year=2018, pages={405-410} }